NCT00532571已完成2 期
Effects of Coenzyme Q10 in PSP and CBD, A Randomized, Placebo-Controlled, Double Blind Cross Over Pilot Study
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Lahey Clinic
- 试验地点
- 2
研究概览
简要总结
To compare the efficacy, safety and tolerability of Coenzyme Q 10 versus placebo in patients with atypical parkinsonian syndromes corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) ).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients fulfilling the diagnostic criteria of PSP and CBD (above) and who were diagnosed within the past 5 years
- •Age > 40
- •Subjects receiving anticholinergics, amantadine, dopamine agonists, carbidopa/levodopa, eldepryl, or comtan must be on a stable dose for at least 30 days prior to baseline visit.
- •Patients agreeable to participate in the study.
排除标准
- •Prior or concurrent therapy with anticholinergics, amantadine,a dopamine agonist,carbidopa/levodopa or comtan within 30 days of the baseline visit.
- •Parkinsons disease or any other atypical parkinsonism; Parkinsonism due to drugs.
- •History of pallidotomy, thalamotomy, deep brain stimulation or fetal tissue transplant.
- •Previous use of coenzyme Q10 within 60 days of the baseline visit.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's DiseaseParkinson's DiseaseNCT00180037Technische Universität Dresden132
招募中
3 期
The effect of Coenzyme Q10 in depressed patientsDepression.Major depressive disorder, single episode, unspecifiedF32.9IRCT20161204031229N5Iran University of Medical Sciences74
已完成
4 期
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated CardiomyopathyDilated CardiomyopathyNCT02115581University of Tehran38
已完成
2 期
Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear PalsyProgressive Supranuclear PalsyNCT00328874German Parkinson Study Group (GPS)20
终止
3 期
Effects of Coenzyme Q10 (CoQ) in Parkinson DiseaseParkinson DiseaseNCT00740714Weill Medical College of Cornell University600
